semaglutide health risks Who Should Consider GLP-1? Semaglutide GLP-1 is generally recommended for individuals with type 2 diabetes who have not achieved adequate blood sugar control with other medications such as metformin, or for Type 2 diabetes: Semaglutide may

Although it is often thought of as a diabetes drug, Ozempic is often prescribed off-label for weight loss, but it is not FDA approved for this use

(Photo illustration by Scott Olson/Getty Images) The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment

FDA-approved brand-name GLP-1 medications (Wegovy, Zepbound) have completed the FDA's drug approval process, which includes review for safety, efficacy, and quality as finished products

Most of the gray market buyers Reuters interviewed had told their medical providers they were taking GLP-1 medicines but not where or how they bought them

Another key question is whether beneficial effects of these drugs extend to all patients with alcohol use disorders and other addictions, a significant minority of whom are underweight. Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments